Om Megashree Pharmaceuticals Set To Offer IPO

Om Megashree Pharmaceuticals, a medicine manufacturing company, is going to launch its IPO starting from February 4, 2025.

The company is releasing the IPO first for Nepali citizens working abroad. People working overseas can apply until February 18, 2025. They can apply for a minimum of 10 shares and a maximum of 10,000 shares. Out of the total capital of 600 million rupees, 30 percent of the shares will be issued to the public, which means 1.8 million shares will be available for everyone. For Nepali workers abroad, 180,000 shares will be available, according to the sales manager, Prabhu Capital.

The company has received a BB- rating from Care Nepal. They produce and import various Ayurvedic medicines and also import and sell surgical goods. As of the end of the current fiscal year (Poush), the company’s earnings per share (EPS) is 98 rupees. The net worth per share is 91.15 rupees. The company’s total accumulated losses are 37.1 million rupees, and they expect the losses to continue this fiscal year.